Latest / Innovation and Private Capital x aulium
Why Drug Trials Take 12 Years and How Biorce Cuts That to 4 - Clara Bernardes
Bringing a drug to market in Europe costs as much as a typical pre-seed round just to comply with AI regulations — before a single line of code is written or a patient enrolled. That bottleneck is slowing innovation at the exact moment AI could cut clinical trial timelines by two-thirds.
Clara Bernardes co-founded Biorce in 2024 to automate the clinical trial lifecycle from phase one to phase three, compressing what typically takes 11–12 years into four or less. The conversation traces the origin story — a terminal melanoma diagnosis, a desperate search for trial access, and the realization…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.